Price T Rowe Associates Inc Pfizer Inc Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 11,252,439 shares of PFE stock, worth $277 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

11,252,439

Previous 21,615,496 47.94%

Holding current value

$277 Million

Previous $548 Million 50.2%

% of portfolio

0.03%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$21.59 - $24.84 $224 Million - $257 Million	-10,363,057 Reduced 47.94%	11,252,439 $273 Million
Q1 2025 May 14, 2025	BUY	$25.01 - $27.13 $68.6 Million - $74.4 Million	2,743,107 Added 14.54%	21,615,496 $548 Million
Q4 2024 Feb 14, 2025	SELL	$24.8 - $30.19 $51.7 Million - $62.9 Million	-2,084,603 Reduced 9.95%	18,872,389 $501 Million
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $107 Million - $121 Million	3,865,041 Added 22.61%	20,956,992 $606 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $203 Million - $238 Million	-8,048,018 Reduced 32.01%	17,091,951 $478 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $140 Million - $161 Million	-5,404,088 Reduced 17.69%	25,139,969 $698 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $483 Million - $627 Million	-18,470,625 Reduced 37.68%	30,544,057 $879 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $527 Million - $616 Million	16,418,085 Added 50.37%	49,014,682 $1.63 Billion
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $159 Million - $184 Million	-4,401,435 Reduced 11.9%	32,596,597 $1.2 Billion
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $44.3 Million - $57.7 Million	1,125,491 Added 3.14%	36,998,032 $1.51 Billion
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $24.9 Million - $32.5 Million	-595,448 Reduced 1.63%	35,872,541 $1.84 Billion
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $66.9 Million - $81.7 Million	1,529,779 Added 4.38%	36,467,989 $1.6 Billion
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $18.8 Million - $22.3 Million	-404,839 Reduced 1.15%	34,938,210 $1.83 Billion
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $362 Million - $449 Million	-7,915,667 Reduced 18.3%	35,343,049 $1.83 Billion
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $168 Million - $249 Million	4,065,502 Added 10.37%	43,258,716 $2.55 Billion
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $585 Million - $751 Million	14,898,367 Added 61.32%	39,193,214 $1.69 Billion
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $36.9 Million - $41.8 Million	1,026,903 Added 4.41%	24,294,847 $951 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $277 Million - $313 Million	-8,284,042 Reduced 26.26%	23,267,944 $843 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $1.06 Billion - $1.34 Billion	31,551,986 New	31,551,986 $1.16 Billion

Others Institutions Holding PFE

# of Institutions

3,291

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Pfizer Inc Transaction History